MODERN APPROACHES TO THE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER

View at publisher Summarise with VIRAT
Authors: S. Melekhov, V. Kononchuk, A. Khristin, S. Sidorov, Lyudmila F Gulyaeva, N. E. Kushlinskii
Cited by: 0
References: 91

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This review summarizes the results of current approaches to the treatment of triple negative breast cancer (TNBC). In addition to conventional chemo-therapy and radiotherapy regimens, modern approaches such as targeted and immunotherapy are discussed. Special attention is given to utilizing data from whole genome DNA sequencing to identify molecular targets for such therapies. The review also discusses reasons for treatment failures and prospects for increasing its efficacy. The latter is linked to the development of new approaches to immunotherapy, the use of PI3K/AKT/mTOR inhibi-tors, cyclin-dependent kinase CDK4/6 inhibitors, and PARP inhibitors in tumors with homologous recombination deficiency (HRD). Further development of these approaches, as well as the emergence of new markers, will allow the application of innovative treatment methods to improve the prognosis and quality of life for patients with TNBC

Fields of Study & Subjects

Breast Cancer Treatment Studies Advanced Breast Cancer Therapies PARP inhibition in cancer therapy

Publication details

Journal / source
Problems of Biological Medical and Pharmaceutical Chemistry
Pages
3–3
Publication date
27 February 2026
Language
EN